Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Bausch Health Companies Inc. | d761372d8k.htm |
| EX-99.1 - EX-99.1 - Bausch Health Companies Inc. | d761372dex991.htm |
 Update on Bausch + Lomb Q2 Performance
(1)
•
Consumer
•
RX Pharma
•
Surgical
•
Contact Lens
•
Generics
Emerging Markets
Other Developed Markets
Organic Growth:
Q2 2014/Q2 2013
22
14%
8%
14%
United States
12%
17%
12%
38%
3%
Country/Region
Notes
(1)
Total
12%
~90% of growth in the U.S. was from volume
Preliminary Estimates
>90% of the growth on a global basis was from volume
Exhibit 99.2 |
 Bausch + Lomb Performance Acquisition through Q2
2014
(1)
•
Consumer
•
RX Pharma
•
Surgical
•
Contact Lens
•
Generics
Emerging Markets
Other Developed Markets
Organic Growth
since acquisition
23
13%
10%
13%
United States
12%
11%
11%
12%
29%
Country/Region
Notes
(1)
Total
11%
~90% of growth in the U.S. was from volume
Preliminary Estimates
>90% of the growth on a global basis was from volume
|